Nektar Therapeutics | NKTR - Current Liabilities

Stock Price
66.29
Daily Change
10.29 18.38%
Monthly
70.98%
Yearly
504.56%
Q1 Forecast
1.21

Nektar Therapeutics reported $66.34M in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
Agios Pharmaceuticals USD 74.76M 4.35M Sep/2025
ALKERMES USD 474.36M 31.6M Sep/2025
Alterity Therapeutics Limited AUD 4.38M 849.82K Jun/2023
Amgen USD 25.49B 3.7B Dec/2025
Baxter International USD 3.78B 836M Sep/2025
BioCryst Pharmaceuticals USD 190.24M 13.08M Sep/2025
Biogen USD 3.35B 59.4M Dec/2025
Bristol-Myers Squibb USD 28.14B 608M Sep/2025
Cara Therapeutics USD 10.68M 9.48M Jun/2025
Cipla INR 62.97B 8.13B Sep/2025
Dr.Reddys Laboratories INR 158.31B 7.38B Dec/2025
Eisai JPY 387.67B 9.42B Dec/2025
Eli Lilly USD 40.14B 1.12B Sep/2025
Esperion Therapeutics USD 359.03M 60.24M Sep/2025
Exelixis USD 405.64M 31.86M Dec/2025
Gilead Sciences USD 11.81B 485M Dec/2025
GlaxoSmithKline GBP 21.39B 57M Dec/2025
Grifols EUR 2.53B 182.67M Sep/2025
Halozyme Therapeutics USD 837.23M 702.95M Sep/2025
Incyte USD 1.52B 176.44M Dec/2025
Ionis Pharmaceuticals USD 903.46M 6.22M Sep/2025
Ironwood Pharmaceuticals USD 242.5M 9.98M Sep/2025
Karyopharm Therapeutics USD 87.16M 12.06M Sep/2025
MacroGenics USD 44.47M 5.47M Sep/2025
Merck USD 28.63B 2.59B Sep/2025
Nektar Therapeutics USD 66.34M 5.05M Sep/2025
Neurocrine Biosciences USD 743.4M 105.4M Dec/2025
Novartis USD 32B 286M Sep/2025
Pfizer USD 36.6B 1.13B Sep/2025
Roche Holding CHF 28B 421M Dec/2025
Sarepta Therapeutics USD 921.42M 1.48M Sep/2025
Takeda JPY 2.61T 470.53B Dec/2025
Teva Pharmaceutical Industries USD 13.46B 1.96B Dec/2025
Xencor USD 86.48M 9.6M Sep/2025